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Abstract
Staphylococcus aureus is an important human pathogen that causes hospital and
community-acquired infections (52). These infections are difficult to treat due to
resistance to a wide range of antibiotics and spread of antibiotic-resistant strains (13, 52).
S. aureus causes infection by regulation of accessory genes encoding for expression of
factors contributing to virulence (9, 11, 12, 29, 34, 43, 45), including severe infection,
biofilm formation, autolysis, and antibiotic resistance (4, 5, 7, 27, 56). Actually,
extracellular DNA and nutrient release during autolysis has been shown to contribute to
the ability of bacteria to form and maintain a biofilm as well as to the prevalence of
resistant strains within a bacterial species (2). The purpose of this study was to determine
the effect msa, a global virulence regulator recently discovered in S. aureus (49, 50), has
on resistance to different cell-wall-active antibiotics. This study also attempted to
generate an allelic replacement vector causing antibiotic susceptibility, confirming the
previous finding by Bae and Schneewind (2008). Population analysis profiles (PAPs) of
twelve different cell-wall-active antibiotics in wild-type and msa mutant versions of
USA300 LAC strain showed msa conferred higher resistance to six antibiotics tested.
This finding supported the presentation of msa as a novel regulation mechanism for
autolysis and antibiotic resistance within S. aureus (47). Also, after transduction of LAC
with the pKOR1 plasmid encoding for chloramphenicol (CAM) resistance, homologous
recombination into the bacterial chromosome, and chromosomal excision and loss of
pKOR1, successful growth of one colony susceptible to CAM was observed. According
to our knowledge, this was only the second time allelic replacement without selection by
antibiotic markers has been produced within the bacterial species.
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Chapter I: Problem
Staphylococcus aureus, named for its characteristic golden yellow, spherical
colonies (52), occurs as normal flora in the nasal passages, skin, digestive tract, and
mouth of humans and is considered the main pathogen responsible for nosocomial, or
hospital-acquired, and community-acquired infections. It is a gram-positive bacterium
able to grow between 15°C and 45°C and also at salt concentrations as high as 15%.
Abilities such as these to survive in the presence of a variety of environmental conditions
explain how S. aureus functions as an increasing pathogen. In strains whose genes
encode for the production of various proteins and toxins that contribute to the capacity to
cause disease within a host system, also known as virulence factors, escalation of diseasecausing cases has been observed. In a study taken of children in south Texas, cases of
community associated-methicillin resistant Staphylococcus aureus (CA-MRSA) infection
increased 14-fold in a two year period up to 2001, and in 2007, CA-MRSA was shown to
be the most prevalent infection of skin and soft tissues in United States emergency
rooms. Diseases caused by S. aureus range from mild, such as boils and styes, to more
severe, such as pneumonia, meningitis, and urinary tract infections, to potentially fatal,
such as osteomyelitis and endocarditis. Treatment of diseases caused by the bacterium
has proven difficult because S. aureus exhibits strong resistance to many antibiotics,
including beta-lactam antibiotics such as methicillin and penicillin (52). From 2002 to
2010, the Centers for Disease Control (CDC) have recorded 11 cases of vancomycinresistant strains of S. aureus (VRSA) causing infection (13), an important finding in that
vancomycin is often used to treat methicilliin-resistant strains. Therefore, understanding
the mechanisms by which genes regulate expression of factors that contribute to
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increased virulence in the species, especially characterizing the pathways of regulation
between these genes, is important for the discovery of new methods to combat the
increasing antibiotic-resistant strains of S. aureus.
S. aureus causes diseases in humans by modulation of a complex regulatory
network of accessory genes (43) that encode for the expression of a variety of virulence
factors (9). SarA (Staphylococcal accessory regulator A), which regulates a number of
genes in S. aureus, is a principal global regulator protein of virulence in the species (11).
Experimentational analysis has shown sarA regulates virulence in S. aureus by binding to
several loci specific as gene promoters, including agr, hla, spa, and fnbA, and thus
controlling specific gene transcription through regulation of agr or even through agrseparate mechanisms (12). The function of sarA is controlled by the global regulatory
gene modulator of sarA (msa), which has been shown to be crucial for complete
expression of sarA and for the function of virulence factors affected by sarA (49, 50). In
S. aureus, sarA has been shown to negatively regulate autolysis (39), which is an
important process in the cell wall synthesis of gram positive bacteria and also significant
to bacterial virulence by causing higher susceptibility to cell-wall-active antibiotics (13,
25, 26). Therefore, I hypothesize that msa may play a role in the resistance or
susceptibility to antibiotics targeted toward cell wall synthesis in S. aureus.
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Chapter II: Literature Review
The principal global regulator sarA, along with agr, another main global regulator
protein of virulence factors in S. aureus (9, 29, 34, 45), has been shown to function in
varied pathogenesis of S. aureus, including the ability of S. aureus to cause severe
infection in host cells. In an experiment determining the functions of sarA and agr, the
inoculation of sarA and agr negative mutant strains into neonatal mice followed by the
quantification of S. aureus strains in the lung and spleen of the mice showed strains
containing sarA and agr loci were essential for fatal pulmonary infection in the host, and
sarA was specifically crucial in order for bacteremia to occur (27). SarA has also been
proven to be essential for pathogenesis of the species in other anatomical sites, as proven
in an experiment infecting the tail vein of neonatal mice with strains of S. aureus
containing sarA and agr as well as sarA and agr mutant versions of the strains, collecting
the bacterial colonies, and analyzing the inflammation response that resulted in the knee
joint, tibia, and femur from the appropriate strains in the infected mice. S. aureus strains
lacking sarA and agr were determined to cause osteomyelitis and septic arthritis less
efficiently than strains containing the two loci (7).
SarA has also been shown to be necessary in the capacity of S. aureus to form
biofilm in six of eight wild-type S. aureus strains tested, UAMS-1, UAMS-601, SA113,
SC-01, S6C, and DB. However, Newman strain was unable to effectively produce a
biofilm that was not significantly changed by mutation of sarA or agr, and RN6390 was
able to form a biofilm even after mutation of sarA. Mutation of agr did not significantly
affect the capacity of RN6390 strain to produce biofilm, yet double mutants of sarA and
agr in RN6390 were unable to produce biofilm. This finding showed the effect of sarA
3

on the production of biofilm is independent of the interaction of sarA and agr (4).
Characterizing this epistatic relationship between sarA and agr in regards to biofilm
formation has therapeutic importance by direct correlation with antibiotic susceptibility
within S. aureus (5). When specifically tested in the presence of a biofilm, sarA mutants
show increased susceptibility to such antibiotics as daptomycin, linezolid, and
vancomycin (56). After induction of agr expression, however, S. aureus cells were
observed to detach from an established biofilm, causing increased susceptibility to a
number of diverse antibiotics, including rifampicin and levofloxacin (8, 37, 38). Agr
mutants have also been observed to accumulate during biofilm formation, becoming the
dominant subpopulation within the biofilm (57), and one report found that loss of agr
function may explain, in part, the selective advantage of clinical glycopeptideintermediate S. aureus (GISA) and clinical MRSA isolates in response to vancomycin
therapy (48). Therefore, sarA expression has been linked to antibiotic resistance in the
context of a biofilm, and agr expression has been correlated with biofilm-associated
susceptibility (5). In relation to its role in the regulation of sarA and sarA-associated
virulence factors, in an experiment testing the ability of msa mutant strains of S. aureus
to form biofilm, use of microtiter plate assay and flow cells to test this ability supported
msa regulates virulence in the species through modulation of sarA. Binding assays and
initial adherence assay supported msa regulates sarA during the accumulation phase of
biofilm formation (49).
Differences observed in vancomycin heteroresistance between several agr
prototype strains has been hypothesized to be related to autolysis since the agr operon has
been found to regulate expression of a number of murein hydrolases involved in this
4

process (19). Murein hydrolases are a ubiquitious class of enzymes among bacteria (21)
found to be involved in many important cellular processes, including growth and
division, daughter cell separation, cell wall synthesis, and turnover and recycling of
peptidoglycan (23, 25, 26, 54). The enzymes function by cleaving the covalent bonds that
make up bacterial cell peptidoglycan (murein), thus priming the peptidoglycan for
expansion of the cell wall. Actually, the break down and build up of cell wall
peptidoglycan has been found to be a dynamic process, in which the murein net is
constantly being hydrolysed and subjected to the addition of new material (28).
Therefore, some murein hydrolases act as autolysins for destruction of the cell wall,
potentially resulting in cellular death, and their expression and activity must be tightly
regulated to ensure proper function and cell survival (28, 19).
As a gram-positive bacteria, S. aureus cell walls are composed of peptidoglycan
cross-linkages. More specifically, short peptide chains cross-link alternating β-1,4-linked
amino sugars made up of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid
(MurNAc), and these short peptides are bound to one another by an amide bond. The
three dimensional structure and rigidity of the cell wall is formed by the peptides linking
to interpeptide bridges having glycan strands. Biosynthesis of the cell wall occurs in
several stages, and specific enzymes catalyze the addition of appropriate peptide to the
growing peptidoglycan chain (51). Figure 1 illustrates the process of peptidoglycan
biosynthesis, including the transglycosylation, or transfer of one glycosidically linked
sugar molecule to another glycoside bond, and transpeptidation, or transfer of amino
acids between peptide bonds, steps and the enzymes involved at each stage. Antibiotics
take advantage of the need for control of the autolysis and cell wall synthesis processes
5

by inhibiting cell wall biosynthesis at a variety of enzymatic steps or through targeting
specific cell-envelope structures involved, as shown in Figure 2 by the mechanism of
inhibition of specific cell-wall-active antibiotics in S. aureus. (13).

Figure 1. Schematic representation of peptidoglycan biosynthesis, including the enzymes
and binding sites of the transglycosylation and transpeptidation steps (17).
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Figure 2. Diagram of the steps and enzymes involved in cell wall synthesis of S.
aureus as well as indication of cell-wall-active antibiotic targets (14).

In response to challenge with cell-wall-active antibiotics, a number of specific
genes are upregulated in expression in S. aureus, which has led to the identification of a
cell wall stress stimulon (CWSS), known as the VraSR two-component system, within S.
aureus (20, 35, 53). This group of genes functions to allow higher tolerance of S. aureus
to cell wall stressors caused by stress-induced genetic signaling events, such as
hydrolysis, synthesis inhibition, and antibiotic disruption of cell wall synthesis (14).
VraSR-TCS is believed to protect against further damage to the cell envelope by inducing
genes that promote peptidoglycan synthesis, including pbp2, the single staphylococcal
penicillin binding protein (PBP) having both transpeptidase and transglycolase activity
7

(44), mgt, a gene encoding for monofunctional glycosyltransferase (55), fmtA, a
penicillin-binding protein interacting specifically with beta-lactam antibiotics (16), murZ,
which encodes for transglycolase activity in the first irreversible step of peptidoglycan
biosynthesis (6), and several other genes whose role in stress response is currently
unknown (32, 33, 35, 40).
In an experiment to determine the effect of sar and agr genes on autolysis within
S. aureus, Triton-X-100 induced and penicillin-induced autolysis of wild type compared
to sar and agr mutants showed decreased autolysis rates among the agr mutants and
increased rate of autolysis among the sar mutants (19). SarA has been determined to
negatively regulate autolysis by repression of sarV, a gene encoding for murein hydrolase
activity (39). Autolytic activity resulting in release of extracellular DNA (eDNA) and
nutrients from dead cells plays a role in the ability of bacteria to produce an effective
biofilm as well as contributes to antibiotic resistance by promotion of horizontal gene
transfer (2), which, in part, explains the effect of sarA on virulence by its regulation of
autolysis. In relation to its regulation of sarA-associated virulence factors, msa gene has
recently been shown to negatively regulate autolysis in a glucose-dependent manner
independent of the cid and lrg murein hydrolase regulatory pathways (46), and this was
related to the inability of the msa mutant to effectively form a mature and established
biofilm (47). This finding presented a novel regulatory mechanism for autolysis
regulation in S. aureus, which therefore has an effect on biofilm formation and antibiotic
resistance within S. aureus (47).
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Chapter III: Methods
Population analysis profiles (PAPs). In order to study the effect msa has on resistance
to different cell-wall-active antibiotics in S. aureus, population analysis profiles for wild
type and msa mutant versions of USA300 LAC strain were performed. Twelve different
cell-wall-active antibiotics, oxacillin, cloxacillin, cephradine, phosphomycin, cefoxitin,
cefotaximine, D-cycloserine, tunicamycin, vancomycin, teicoplanin, ramoplanin, and
flavomycin, were tested. Based on the MICs (minimum inhibitory concentrations) for
each antibiotic tested, TSA (tryptic soy agar) and MHA (Mueller-Hinton agar) with 2%
NaCl agar cultures containing serial dilutions of the appropriate antibiotic were made.
The wild type, msa mutant, and complement to the wild type strains were grown at 37˚C
for 24 hours in TSB (tryptic soy broth) or MHB (Mueller-Hinton broth) with 2% NaCl,
respectively, then diluted to 10-6 and inoculated onto the appropriate agar cultures. After
incubation at 37˚C for 24 hours, the resulting colonies were counted and antibiotic
concentration was compared to amount of growth.
Allelic Replacement of pKOR1. Allelic replacement of pKOR1 plasmid into S. aureus
USA300 LAC strain was also performed as a means to generate a susceptible strain
without the need for antibiotic marker selection. After transduction of the pKOR1
plasmid, which codes for chloramphenicol (CAM) resistance, into LAC, the strain was
grown on TSA with 10 µg/mL of CAM at 30ºC for 24 hours. Several colonies were then
transferred to a broth culture of TSB with 10 µg/mL CAM and grown at 43ºC, a nonpermissive temperature for pKOR1 replication (18), for 24 hours. The broth culture was
then inoculated onto a TSA with 10 µg/mL CAM agar plate and incubated at 43ºC for 24
hours, and the resulting colonies were grown in TSB broth culture at 30ºC for 24 hours.
9

Each overnight culture was diluted to 10-4 with sterile H2O and spread onto TSA with
100 ng anhydro-tetracyclin (ATc) as well as TSA as a positive control and incubated at
30ºC for 24 hours. Colonies were transferred from the ATc plate onto TSA with 10
µg/mL CAM as well as TSA and grown at 37ºC for 24 hours. Chromosomal DNA from
the colonies sensitive to CAM was harvested, and a specific region surrounding the msa
gene was amplified by PCR with terminal attB forward and reverse primers.
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Chapter IV: Results

Figure 3.1. Graph comparing the growth percentage of wild-type USA300 LAC and msa
mutant strains under exposure to serial concentrations in µg/mL of oxacillin.

In the presence of oxacillin ranging from 1.5 µg/mL to 200 µg/mL, the msa mutant strain
had a lower growth percentage than the LAC strain as observed from the number of
resulting colonies after population analysis. The number of colonies observed at 0 µg/mL
of oxacillin was considered 100% growth.

Figure 3.2. Graph comparing the growth percentage of wild-type USA300 LAC and msa
mutant strains under exposure to serial concentrations in µg/mL of phosphomycin.
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Upon exposure to 1.56 µg/mL to 12.5 µg/mL serial concentrations of phosphomycin, the
msa mutant had a lower growth percentage than wild-type LAC and complement to wildtype LAC as observed from the number of resulting colonies after population analysis.
No growth was observed in LAC, complement to LAC, or the msa mutant in serial
concentrations above 12.5 µg/mL. The number of colonies observed at 0 µg/mL of
phosphomycin was considered 100% growth.

Figure 3.3. Graph comparing the growth percentage of wild-type USA300 LAC and msa
mutant strains under exposure to serial concentrations in µg/mL of vancomycin.

After population analysis in the presence of vancomycin at the serial concentrations of
0.125 µg/mL and 0.25 µg/mL, the msa mutant had a lower growth percentage than the
wild-type LAC as observed from the number of resulting colonies after population
analysis. No growth was observed for either strain at serial concentrations above 0.25
µg/mL. The number of colonies observed at 0 µg/mL of vancomycin was considered
100% growth.
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Figure 3.4. Graph comparing the growth percentage of wild-type USA300 LAC and msa
mutant strains under exposure to serial concentrations in µg/mL of teicoplanin.

Similar to vancomycin, the msa mutant had a lower growth percentage compared to wildtype LAC at 0.125 µg/mL and 0.25 µg/mL serial concentrations of teicoplanin after
population analysis, and no growth was observed in either strain at serial concentrations
of teicoplanin above 0.25 µg/mL. The number of colonies observed at 0 µg/mL of
teicoplanin was considered 100% growth.

Figure 3.5. Graph comparing the growth percentage of wild-type USA300 LAC and msa
mutant strains under exposure to serial concentrations in µg/mL of flavomycin.
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Population analysis of the msa mutant and wild-type LAC strains with flavomycin
resulted in lower growth percentage of the msa mutant strain compared to the wild-type
LAC strain at serial concentrations ranging from 0.75 µg/mL to 100 µg/mL of
flavomycin. The number of colonies growing at 0 µg/mL was considered 100% growth.

Figure 3.6. Graph comparing the growth percentage of wild-type USA300 LAC and msa
mutant strains under exposure to serial concentrations in µg/mL of ramoplanin.

In the presence of ramoplanin at serial concentrations of 0.15625 µg/mL, 0.3125 µg/mL,
0.625 µg/mL, and 1.25 µg/mL, the msa mutant strain had a lower growth percentage than
the wild-type LAC strain as observed from the number of resulting colonies after
population analysis. No growth resulted for either strain at serial concentrations above
1.25 µg/mL of ramoplanin. The number of colonies observed at 0 µg/mL of ramoplanin
was considered 100% growth.
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Figure 4. Gel electrophoresis of msa operon and the 1.5 kb region surrounding msa
operon after deletion of msa gene by allelic replacement using pKOR1 in wild-type
USA300 LAC strain. The first lane represents the msa operon, and the next five lanes
represent the region containing the deleted msa gene. The seventh lane contains the 1 kb
DNA Ladder.

Regarding the allelic replacement of pKOR1 in LAC strain, the screening of more than
200 colonies on TSA with 10 µg/mL of CAM and TSA resulted in one colony that was
sensitive to CAM but was able to grow on TSA. PCR with terminal attB primers of the
chromosomal DNA and electrophoresis on a 1% agarose gel showed a 1.5 kb band,
verifying the msa gene had been deleted in the specific region of DNA amplified by attB
primers. Using terminal attB primers, the msa operon in LAC strain was also amplified
by PCR as a control, and the presence of a band in the 3 kb region of the gel verified
presence of the msa operon.
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Chapter V: Discussion
As indicated by Figures 3.1-3.6, the msa mutant strain showed higher
susceptibility than the wild-type LAC strain to oxacillin, phosphomycin, vancomycin,
teicoplanin, ramoplanin, and flavomycin when the growth percentage was compared to
the antibiotic concentration each culture was exposed to after population analysis.
Therefore, presence of the msa gene was determined to be correlated with antibiotic
resistance to certain cell-wall-active antibiotics in S. aureus. The specific mechanism by
which msa confers this resistance is still unknown at this time. It is known that oxacillin
blocks cell wall synthesis by binding the transpeptidase active domain of PBPs
(penicillin-binding proteins) (22), and flavomycin binds the transglycosylase domain of
PBP2 for inhibition of transglycosylation (24). Also, phosphomycin inhibits MurA
activity (30), which is an enzyme encoded by murA, an isozyme of murZ (6).
Vancomycin and teicoplanin have been determined to function as glycopeptide
antibiotics by binding to Lipid II of the cytoplasmic membrane and preventing
transglycosylation and transpeptidation (3), and ramoplanin has also been found to
prevent transglycolysation by binding to Lipid II (17). By future studies on the genes
involved in stress response to cell-wall-active antibiotics and their correlation to msa, the
function of msa as a regulator of antibiotic resistance within S. aureus could be better
understood.
Since pKOR1 is unable to replicate at 43˚C, growth of the LAC strain carrying
this plasmid selected for homologous recombination of pKOR1 into the bacterial
chromosome (18). Following this step, growth of the strain on ATc selected for colonies
lacking the plasmid since ATc induces the Pxyl/tetO promoter of pKOR1 to encode for
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secY antisense transcripts, a condition which does not permit staphylococcal growth (1).
Growth of the resulting colonies on TSA with CAM as well as TSA verified loss of the
plasmid by selection of colonies sensitive to CAM. As further verification that pKOR1
allowed for allelic replacement of the msa gene within the strain, the msa operon was
amplified by PCR using terminal attB primers (15). The gel electrophoresis as shown by
Figure 4 resulted in presence of a band in the 1.5 kb region, indicating the msa gene had
been deleted in the DNA region amplified. PCR amplification of the msa operon without
the deleted msa gene in the LAC strain served as a control, verifying PCR using terminal
attB primers of the msa operon successful by observed presence of a band in the 3 kb
region of the gel after electrohporesis. This experiment confirmed the former finding by
Bae and Schneewind (2005) that allelic replacement can be accomplished in low
frequencies using pKOR1 in S. aureus, and to our knowledge, presents for the second
time use of an allelic replacement vector to create antibiotic-susceptible strains without
the need for antibiotic marker selection. Also, according to our knowledge, this
experiment presented for the first time allelic replacement of the msa gene in S. aureus
using an allelic replacement vector without the need for antibiotic markers to select for
susceptibility. Bae and Schneewind (2005) used attB primers to amplify 1 kb regions
upstream and downstream of the rocA gene, a gene encoding for an enzyme involved in
proline degradation in S. aureus (15), in order to confirm successful allelic replacement.
It was concluded from this project that msa plays a role in antibiotic susceptibility
within S. aureus by conferring a higher resistance to certain cell-wall-active antibiotics.
Since it has previously been determined that msa affects the ability of S. aureus to
produce a mature biofilm through its regulation of sarA (49), and since the ability of S.
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aureus to effectively form a biofilm has been directly correlated with specific antibiotic
resistance or susceptibility through agr-dependent and sar-dependent regulation (5, 8, 37,
38, 48, 56), future studies on the effect of msa on antibiotic susceptibility or resistance in
the context of a biofilm could determine the relationship between msa and the sar and
agr global virulence regulators. This could have therapeutic importance by determination
of the genetic mechanism by which S. aureus produces a biofilm for increased resistance
as well as shows a selective advantage to certain antibiotic treatments.
By inserting DNA into pKOR1 through recombination without the need for
plasmid inserts to clone the DNA, the cloning process for a specific DNA region was
made more rapid (1). This experiment also confirmed that pKOR1 can be used as an
allelic replacement vector in order to counter-select for the plasmid replication marker in
other S. aureus strains as well as select for allelic replacement of specific genes in S.
aureus. Since ATc was found to successfully inhibit growth of strains carrying pKOR1,
this experiment provided a possible treatment for antibiotic-resistant strains created
through allelic replacement by plasmid recombination. Actually, ATc was found to select
against growth of strains carrying pKOR1 even at 50 ng/mL concentrations of ATc (1).
Future experiments using pKOR1 to induce counter-selection of strains carrying
virulence genes in S. aureus could thus provide a novel possible treatment for certain S.
aureus strains of clinical importance.
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